NDC11 76329366902
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 76329-3669-02 | 76329-3669 |
| 76329-3669-2 | 76329-3669 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| REXTOVY | NALOXONE HYDROCHLORIDE | International Medication Systems, Ltd. | fe9735db-c57e-44a8-bffb-b87a84c2a6f3 | 2024-05-15 | Warnings, Adverse reactions | 76329-3669-2 76329-3669 76329366902 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.